Page 1

Q3 Quarterly Statement Third Quarter of 2021 Bayer grows sales and earnings significantly BAYER BAYER // Group sales at € 9.8 billion ( Fx & p adj . + 14.3 % ) // EBITDA before special items increases to € 2.1 billion ( + 16.4 % ) // Crop Science reports strong increase in sales and earnings // Pharmaceuticals and Consumer Health again post considerable sales growth // Core earnings per share at € 1.05 ( + 29.6 % ) // Net income at € 0.1 billion // Free cash flow remains strong at € 2.0 billion // Revised outlook confirms good business performance Science for a better life